GSK3B and glioblastoma: In temozolomide (TMZ)-resistant glioblastoma multiforme (GBM), miR-101 downregulation led to GSK3β upregulation, promoting O6-methylguanine-DNA methyltransferase (MGMT) expression and resistance, while miR-101 overexpression sensitized cells to TMZ.26